Melatonin: The Supplement We Misunderstand
It's the most-used sleep aid in America, and almost nobody is taking it the way the science suggests — the right dose, for the right problem, at the right time.
Melatonin is the most widely used sleep supplement in the world and one of the most widely misunderstood. Walk into any pharmacy or grocery store and you will find dozens of products — gummies, capsules, sprays, and teas — each promising better sleep through melatonin. Most of them come in doses of 5, 10, or even 20 milligrams. Most of the people who take them are using them for the wrong reason, at the wrong dose, at the wrong time.
What melatonin actually is, what it actually does, and where it legitimately helps are dramatically different from the popular understanding. Getting this right is not pedantic; it is the difference between using a tool appropriately and wasting money on a supplement that is not suited to your situation — or, in some cases, potentially making things worse.
What Melatonin Actually Does in the Brain
Melatonin is a hormone produced by the pineal gland in response to darkness. Its physiological function is not to induce sedation — it is to signal to the brain and body that it is nighttime, communicating timing information to the circadian system. Melatonin is a chronobiotic: it modulates the timing of biological rhythms. It is not a sedative.
This distinction is critical and almost universally missed by consumers. When people take melatonin hoping that it will knock them out the way a sleeping pill does, they are expecting pharmacology that melatonin does not produce at normal endogenous levels or at clinically studied doses. The sleepiness some people feel after taking melatonin is likely the result of taking doses far higher than those that produce chronobiotic effects, combined with the expectation (and placebo) of sleepiness — not a direct sedating action comparable to benzodiazepines or antihistamines.
Endogenous melatonin levels rise approximately one to two hours before habitual sleep time, peak in the middle of the night, and fall as morning approaches. The amplitude of this rise — from near-zero daytime levels to nighttime peaks — communicates the timing of the dark phase to every cell in the body through the MT1 and MT2 receptors expressed throughout the brain and peripheral organs. This signal helps consolidate the timing of sleep, not its depth or duration.
Where Melatonin Actually Works: Circadian Applications
Given its chronobiotic mechanism, melatonin is most appropriately used to shift the timing of the circadian clock in situations where circadian misalignment is the problem. These are the applications with the strongest evidence.
Jet Lag
Jet lag occurs when the circadian clock is misaligned with the local light-dark cycle after rapid transmeridian travel. Melatonin taken at the appropriate local bedtime at the destination can accelerate circadian re-entrainment, reducing the number of days of jet lag symptoms. A 2002 Cochrane review found that melatonin was effective for preventing or reducing jet lag when taken at bedtime at the destination after crossing five or more time zones. The effective dose in these studies was typically 0.5 to 5 mg — and higher doses (5 mg and above) were not more effective than lower doses in most analyses.
Shift Work
Shift workers who need to sleep during the day and work at night face chronic circadian misalignment. Melatonin taken before the intended daytime sleep period can modestly improve daytime sleep quality and duration. The evidence is less consistent than for jet lag, but melatonin is a reasonable adjunct for shift workers trying to consolidate daytime sleep, particularly in combination with environmental modifications (blackout curtains, noise reduction).
Delayed Sleep Phase Disorder
Delayed sleep phase disorder (DSPD) is a circadian rhythm disorder in which the biological sleep-wake cycle is shifted significantly later than conventional social schedules require. Affected individuals feel alert late at night and struggle to fall asleep before 1 to 3 a.m., with corresponding difficulty waking in the morning. Melatonin taken five to seven hours before the existing sleep time — at what would be the "phase advance point" on the circadian clock — can gradually advance the sleep phase toward earlier timing. This application requires careful timing and gradual dose adjustment and is best managed under medical supervision.
Where Melatonin Does Not Work: Chronic Insomnia
For the most common sleep complaint — chronic insomnia characterized by difficulty falling asleep, staying asleep, or waking too early, with associated daytime impairment — melatonin has weak evidence at best. Multiple randomized controlled trials and meta-analyses have found that melatonin produces modest reductions in sleep onset latency (approximately seven to twelve minutes) and no significant improvements in wake after sleep onset, sleep efficiency, or total sleep time in adults with chronic insomnia whose circadian timing is normal.
A comprehensive 2013 meta-analysis in PLOS ONE examining melatonin for sleep disorders found that in primary insomnia (the diagnostic category most comparable to chronic behavioral insomnia), melatonin produced a statistically significant but clinically small reduction in sleep onset latency, with no significant effect on sleep quality or total sleep time. The authors concluded that melatonin was not recommended as a treatment for primary insomnia.
This finding makes sense given the mechanism. If chronic insomnia is driven by conditioned arousal, maladaptive sleep beliefs, and behavioral patterns that maintain wakefulness — the factors that CBT-I addresses — a supplement that modulates circadian timing does not address any of these factors. Taking melatonin for behavioral insomnia is, in a sense, treating a fever with a calendar.
The Dosing Problem
The melatonin dosing landscape in the United States is a regulatory anomaly. Unlike in most other countries, where melatonin is regulated as a medication (available at pharmacologically active doses typically of 0.5 to 2 mg, with prescriptions required above certain doses), the U.S. classifies melatonin as a dietary supplement. This means there is no regulatory limit on the dose in commercial products and no requirement for clinical evidence of efficacy at the doses sold.
The result is a market saturated with products containing doses of 5, 10, or 20 mg — far above the doses used in clinical research and far above the physiological doses that produce chronobiotic effects. A 2023 study published in JAMA found that melatonin gummies in particular frequently contain substantially more melatonin than their labels claim, with some products containing more than five times the labeled dose.
Research on endogenous melatonin physiology suggests that the chronobiotic effect is achieved at doses as low as 0.3 to 1 mg — amounts that produce blood levels comparable to the natural nighttime rise. Higher doses produce pharmacologically elevated melatonin levels that are orders of magnitude above normal physiological levels, the long-term consequences of which for sleep regulation, hormonal function, and other systems are not well-studied.
The practical implication: if you are using melatonin for jet lag or circadian reasons, the appropriate dose is likely 0.5 to 1 mg — not the 10 mg gummies that dominate retail shelves. Starting at the lowest effective dose and titrating up only if needed is the evidence-based approach.
Safety Considerations
Melatonin at low doses for short-term use has a good safety profile in adults. The most common adverse effects at standard doses are headache, dizziness, and next-day grogginess, particularly at higher doses with longer half-lives.
Concerns about chronic high-dose melatonin use center on the potential for exogenous melatonin to suppress endogenous production, disrupt other hormonal systems (melatonin has complex interactions with reproductive hormones), and produce unknown long-term effects at the supraphysiological levels created by typical commercial doses. These concerns are not well-studied in adult populations but are more significant for children, where long-term safety data is largely absent.
Pediatric use of melatonin has increased dramatically in recent years, including in very young children. The American Academy of Pediatrics has issued guidance cautioning against chronic melatonin use in children and adolescents without medical supervision, citing the lack of long-term safety data and the importance of addressing behavioral causes of pediatric insomnia before supplementation.
Alternatives That Actually Address Chronic Insomnia
For people taking melatonin hoping to resolve chronic insomnia, the most useful reframe is that they are treating a behavioral and cognitive disorder with a circadian supplement. CBT-I is the evidence-based treatment for chronic insomnia, with large effect sizes for sleep onset latency, wake after sleep onset, and insomnia severity, and with gains that persist and improve after treatment ends.
The components of CBT-I — sleep restriction, stimulus control, cognitive restructuring, relaxation training — address the actual mechanisms maintaining insomnia: conditioned arousal, excessive time in bed, maladaptive beliefs about sleep, and physiological hyperarousal. Melatonin addresses none of these.
For people whose sleep problem is primarily circadian — they feel genuinely unable to sleep until very late at night, regardless of effort, and struggle to wake at conventional times — melatonin at the correct timing may be a useful tool alongside bright light therapy and circadian behavioral strategies. This is a more specific indication than most melatonin users recognize themselves as having.
Using Melatonin Intelligently
If you use melatonin, the evidence suggests a few practical principles. Use the lowest effective dose — typically 0.5 to 1 mg is sufficient for chronobiotic effects. Take it at consistent timing: for sleep onset issues related to circadian delay, take it 30 to 60 minutes before the desired sleep time. For jet lag, take it at the local bedtime of your destination. Do not take it hoping for a sedating effect — that is not its mechanism at physiological doses.
If you have taken high-dose melatonin regularly for a long time, reducing the dose gradually rather than stopping abruptly is reasonable to avoid any transient adjustment. If your sleep problem is chronic insomnia rather than jet lag or circadian misalignment, consider whether CBT-I — the treatment with the actual evidence base for your condition — might be a more appropriate investment.
Frequently Asked Questions
What dose of melatonin is actually effective?
Clinical research suggests doses of 0.3 to 1 mg produce chronobiotic effects comparable to endogenous melatonin levels. Most commercial products in the U.S. contain 5 to 10 mg, which is far above the studied clinical dose. There is no evidence that higher doses produce proportionally greater benefits for sleep timing, and higher doses are more likely to cause next-day grogginess.
Is melatonin safe for long-term use?
Long-term safety data is limited, particularly at the high doses common in U.S. commercial products. Short-term use at low doses (under 2 mg) has a good safety profile in adults. Chronic use at supraphysiological doses and long-term use in children are the areas of greatest uncertainty. For chronic insomnia, CBT-I is preferable to ongoing melatonin use because it addresses the root cause rather than masking symptoms.
Why doesn't melatonin work for my insomnia?
Because melatonin is a circadian timing signal, not a sedative or sleep-inducing medication. If your insomnia is driven by conditioned arousal, excessive time in bed, performance anxiety about sleep, or stress-related hyperarousal, melatonin does not address any of these mechanisms. CBT-I targets the behavioral and cognitive factors that actually maintain chronic insomnia.
Can I use melatonin for jet lag?
Yes — this is melatonin's best-supported application. Take 0.5 to 2 mg at the local bedtime of your destination for the first two to three nights after arrival. This helps accelerate re-synchronization of the circadian clock. The effect is most meaningful for eastward travel of five or more time zones, where adjustment is typically harder.
Disclosure
Sleep Editorial is an independent publication. This article was reported and written without compensation from any product or service mentioned. Sleep Editorial does not provide medical advice; consult a qualified clinician for diagnosis and treatment.
More from Medication vs. Natural